Goldman Sachs’s Loxo Oncology, Inc LOXO Stock Holding History

Goldman Sachs’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-232,815	Closed	-$32.6M	–	5642
2018 Q4	$32.6M	Buy	232,815 +26,747	+13%	+$4.06M	0.01%	1417
2018 Q3	$35.2M	Sell	206,068 -31,150	-13%	-$5.23M	0.01%	1475
2018 Q2	$41.2M	Buy	237,218 +66,064	+39%	+$9.93M	0.01%	1353
2018 Q1	$19.7M	Buy	171,154 +65,133	+61%	+$6.93M	0.01%	1872
2017 Q4	$8.93M	Sell	106,021 -12,190	-10%	-$1.02M	﹤0.01%	2543
2017 Q3	$10.9M	Buy	118,211 +28,983	+32%	+$2.25M	﹤0.01%	2490
2017 Q2	$7.16M	Buy	89,228 +45,050	+102%	+$2.5M	﹤0.01%	2772
2017 Q1	$1.86M	Buy	44,178 +2,045	+5%	+$84.2K	﹤0.01%	3818
2016 Q4	$1.35M	Buy	+42,133	New	+$1.08M	﹤0.01%	4195
2015 Q2	–	Sell	-30,547	Closed	-$380K	–	7552
2015 Q1	$380K	Buy	30,547 +1,440	+5%	+$17.9K	﹤0.01%	5408
2014 Q4	$342K	Sell	29,107 -10,933	-27%	-$127K	﹤0.01%	5648
2014 Q3	$526K	Buy	+40,040	New	+$520K	﹤0.01%	5222

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Goldman Sachs's LOXO Position: Q1 2019 in Review

Goldman Sachs sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 232,815 shares — an estimated $32.6M sold.

Goldman Sachs first reported a position in LOXO in Q3 2014 and held it in 12 quarters. The position peaked at $41.2M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Goldman Sachs reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Goldman Sachs sold 232,815 Loxo Oncology, Inc shares in Q1 2019, an estimated $32.6M.
Goldman Sachs first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 12 quarters.
Goldman Sachs's Loxo Oncology, Inc position peaked at $41.2M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.